FR2908892B1 - PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS - Google Patents
PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONSInfo
- Publication number
- FR2908892B1 FR2908892B1 FR0610181A FR0610181A FR2908892B1 FR 2908892 B1 FR2908892 B1 FR 2908892B1 FR 0610181 A FR0610181 A FR 0610181A FR 0610181 A FR0610181 A FR 0610181A FR 2908892 B1 FR2908892 B1 FR 2908892B1
- Authority
- FR
- France
- Prior art keywords
- activity
- factor viii
- chromogenic assay
- plasmas
- need
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4728—Details alpha-Glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90287—Oxidoreductases (1.) oxidising metal ions (1.16)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0610181A FR2908892B1 (en) | 2006-11-21 | 2006-11-21 | PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0610181A FR2908892B1 (en) | 2006-11-21 | 2006-11-21 | PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2908892A1 FR2908892A1 (en) | 2008-05-23 |
FR2908892B1 true FR2908892B1 (en) | 2009-02-20 |
Family
ID=38222712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0610181A Expired - Fee Related FR2908892B1 (en) | 2006-11-21 | 2006-11-21 | PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2908892B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102798598A (en) * | 2011-05-25 | 2012-11-28 | 兆科药业(合肥)有限公司 | Method for detecting enzymatic activity of phospholipid-depending factor X activator |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60186760A (en) * | 1984-03-05 | 1985-09-24 | Sekisui Chem Co Ltd | Blood coagulation accelerator |
CA2065370C (en) * | 1990-07-12 | 2000-04-04 | Hendrik Coenraad Hemker | Factor viii:ca chromogenic assay |
JPH08327631A (en) * | 1995-06-01 | 1996-12-13 | Eisai Co Ltd | Reagent for measuring blood coagulation activity |
DE69801210T2 (en) * | 1998-03-19 | 2002-05-02 | Instrumentation Laboratory S.P.A., Mailand/Milano | Improved in vitro procedures, test kits and reagents for screening blood clotting defects |
DK1194161T3 (en) * | 1999-07-13 | 2006-02-13 | Biovitrum Ab | Stable factor VIII compositions |
-
2006
- 2006-11-21 FR FR0610181A patent/FR2908892B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2908892A1 (en) | 2008-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR15C0046I2 (en) | DRUGS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | |
FR2882654B1 (en) | USE OF DIOSMETIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF THROMBOTIC DISEASES | |
FR13C0060I2 (en) | FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS | |
NO20034388D0 (en) | Therapeutic agent for chronic arthritis diseases in child-related diseases | |
ES2983099T3 (en) | Process for the concentration of antibodies and therapeutic products from them | |
FR2906808B1 (en) | USE OF MONOCLONAL ANTIBODIES SPECIFIC TO THE O-ACETYLATED FORMS OF GANGLIOSIDE GD2 IN THE TREATMENT OF CERTAIN CANCERS | |
CL2007003155A1 (en) | COMPOUNDS DERIVED FROM 3,7-DIAZABICICLO [3.3.0] OCTANO OR 3,7-DIAZABICICLO [3.3.1] NONANO, NEURONAL NICOTINIC RECEIVER MODULATORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CNS DISORDERS. | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
ATE512948T1 (en) | BIPHENYL-SULFONYL AND PHENYL-HETEROARYL-SULFONYL MODULATORS OF THE HISTAMINE H3 RECEPTOR FOR THE TREATMENT OF RELATED DISEASES | |
FR2900734B1 (en) | DETECTION OF THROMBOEMBOLIC VENOUS DISEASES BY THE ASSAY OF D-DIMERS AND SOLUBLE FIBRIN | |
FR2854074B1 (en) | USE OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | |
FR2887141B1 (en) | COMPRESSIVE ORTHESIS TRICOTEE OF THE LOWER MEMBER FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY | |
FR2900157B1 (en) | PROCESS FOR THE DESULFURATION OF OLEFINIC ESSENCES COMPRISING AT LEAST TWO DISTINCT HYDRODESULFURATION STAGES | |
ATE424823T1 (en) | 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCINOLINE DERIVATIVES AS MEDICINAL PRODUCTS FOR THE TREATMENT OF INFERTILITY | |
FR2891163B1 (en) | CATALYST FOR THE PREPARATION OF PENTAFLUOROETHANE AND THE PROCESS OF PREPARATION THEREOF | |
FR2883182B1 (en) | VITAMIN COMPOSITION USEFUL IN THE TREATMENT OF OCULAR DISEASES | |
ATE406895T1 (en) | 4-PHENYL-5-OXO-L,4,5,6,7,8-HEXAHYDROCINOLINE DERIVATIVES AS MEDICINAL PRODUCTS FOR THE TREATMENT OF INFERTILITY | |
FR2919187B1 (en) | USE OF YEAST SKIN FOR THE TREATMENT AND / OR PREVENTION OF HYPERINSULINEMIA. | |
FR2886852B1 (en) | COMPOSITION BASED ON AVERMECTIN AND HYDROCORTISONE, IN PARTICULAR FOR THE TREATMENT OF ROSACEA | |
FR2889068B1 (en) | NOVEL DAIRY PROTEIN FRACTIONS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | |
FR2903999B1 (en) | MODULATORS OF SC4MOL IN THE TREATMENT OF ACNE OR HYPERSEBORRHEA | |
FR2908892B1 (en) | PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS | |
FR2911849B1 (en) | PURIFYING THE PROCESSING AND BURNING OF TWO BOTTLES OR BOTTLES | |
FR2876375B1 (en) | PROCESS FOR THE PREPARATION OF (METH) ACRYLIC ESTERS OR ANYDRIDES | |
DE602004010172D1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF KIDNEY FUNCTIONAL DISORDERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
ST | Notification of lapse |
Effective date: 20220705 |